Immuno-oncology Therapy Market, 2022 by Therapy Type and by Therapeutic Areas for Hospitals, Clinics and Cancer Research Institutes – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Immuno-oncology
Therapy Market by Therapy Type and by Therapeutic Areas, for Hospitals,
Clinics and Cancer Research Institutes: Global Industry Perspective,
Comprehensive Analysis and Forecast, 2016 – 2022”
report has
been added to ResearchAndMarkets.com’s offering.

The study provides a decisive view on the immuno-oncology therapy market
by segmenting the market based on therapy type, therapeutic area,
end-user, and regions. All the segments have been analyzed based on
present and future trends and the market is estimated from 2016 to 2022.

Scope of the Report

  • Based on therapy type the market is segmented into monoclonal
    antibodies, immune checkpoint inhibitors (PD1/ PDL1 and CTLA-4),
    immune system modulators, cancer vaccines and others.
  • Based on the therapeutic area the market is segmented into lung
    cancer, colorectal cancer, breast cancer, prostate cancer, melanoma,
    blood cancer and other cancers.
  • Key end-users covered under this study include hospitals, clinics,
    ASCs and cancer research institutes.
  • This segmentation includes demand for immuno-oncology therapy market
    based on individual therapy type, therapeutic area and end-users in
    all the regions and countries.

Market Dynamics

Market Drivers

  • Highly Promising Treatment Pipeline
  • Increase in Number of Patients Suffering from Various Cancers
  • Greater Efficiency Over Conventional Treatment Methods

Market Restraints

  • High Level of Attrition within the Development Cycles
  • Stringent Regulatory Framework
  • Lack of Awareness of Immunotherapy

Opportunities

  • Developed Economies Showing Higher Development Rates

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Immuno-oncology Therapy Market Market Dynamics

4. Global Immuno-oncology Therapy Market Competitive Landscape

5. Global Immuno-oncology Therapy Market Therapy Type Segment Analysis

6. Global Immuno-oncology Therapy Market Therapeutic Area Segment
Analysis

7. Global Immuno-oncology Therapy Market End-User Segment Analysis

8. Global Immuno-oncology Therapy Market Regional Segment Analysis

9. Company Profiles

  • Amgen, Inc.
  • AstraZeneca Plc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F.Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc.
  • Janssen Biotech
  • Merck and Co.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi
  • Spectrum Pharmaceuticals, Inc.
  • Takeda Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/3llcvh/immunooncology?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Hospital
Management
, Drug
Discovery
, Oncology
Drugs